Related Experiment Video
Updated: Sep 1, 2025
08:05
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
14.3K
Post-COVID lung disease(s).
Michel Achkar1,2, Omar Jamal1,2, Toufic Chaaban1,2
1Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, Lebanon.
Annals of Thoracic Medicine
|August 15, 2022
Summary
Post-COVID lung disease, including fibrosis, is a significant concern. This review summarizes current evidence and suggests guidance for evaluating and managing patients with persistent respiratory symptoms after COVID-19.
Area of Science:
- Pulmonology
- Infectious Diseases
- Radiology
Background:
- Post-COVID lung impairment is a growing public health issue.
- Diffuse parenchymal lung disease and fibrosis are primary concerns following COVID-19 infection.
- Multiple factors contribute to persistent respiratory symptoms after COVID-19.
Purpose of the Study:
- To review and summarize existing evidence on the radiological, physiological, and histopathological features of post-COVID lung diseases.
- To provide guidance for the evaluation of patients with post-COVID lung conditions.
- To highlight management strategies and identify knowledge gaps in treating these conditions.
Main Methods:
- A comprehensive search of the PubMed database was conducted for English literature.
- Evidence regarding radiological, physiological, and histopathological aspects was systematically summarized.
- Clinical guidance for patient evaluation and management was developed based on the reviewed literature.
Main Results:
- The review consolidates current understanding of lung damage post-COVID-19.
- Diagnostic and management pathways are proposed for affected individuals.
- Key areas for future research, particularly in pharmacotherapy, are identified.
Conclusions:
- Post-COVID lung disease requires structured evaluation and management protocols.
- Further research into treatments like corticosteroids and antifibrotics is crucial.
- Addressing knowledge gaps will improve patient outcomes for respiratory complications of COVID-19.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
480
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
480
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.0K
01:17Pulmonary Cycle: Exhalation
1.7K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.7K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:29Pneumonia II: Pathophysiology
457
The pathophysiology of pneumonia involves the following steps:
457